{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:00:59Z","timestamp":1777705259804,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.chest.2020.06.044","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T21:14:28Z","timestamp":1593724468000},"page":"2314-2322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["BAL Inflammatory Markers Can Predict Pulmonary Exacerbations in Children With Cystic Fibrosis"],"prefix":"10.1016","volume":"158","author":[{"given":"Alya","family":"Ishak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Stick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidija","family":"Turkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarath C.","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Sly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daan","family":"Caudri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.chest.2020.06.044_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ppul.21117","article-title":"Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis","volume":"45","author":"Sanders","year":"2010","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.chest.2020.06.044_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1183\/09031936.00159111","article-title":"Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis","volume":"40","author":"Waters","year":"2012","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.chest.2020.06.044_bib3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/thx.2006.060897","article-title":"Exacerbations in cystic fibrosis: 2. prevention","volume":"62","author":"Bell","year":"2007","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.chest.2020.06.044_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcf.2013.07.006","article-title":"Pulmonary exacerbations in CF patients with early lung disease","volume":"13","author":"Anstead","year":"2014","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.chest.2020.06.044_bib5","series-title":"2015 Annual Data Report","year":"2016"},{"issue":"21","key":"10.1016\/j.chest.2020.06.044_bib6","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1301725","article-title":"Risk factors for bronchiectasis in children with cystic fibrosis","volume":"368","author":"Sly","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.chest.2020.06.044_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2009.05.005","article-title":"Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening","volume":"155","author":"Stick","year":"2009","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.chest.2020.06.044_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00408-017-0024-3","article-title":"Clinically promising biomarkers in cystic fibrosis pulmonary exacerbations","volume":"195","author":"Scott","year":"2017","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.chest.2020.06.044_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ppul.23636","article-title":"Induced sputum to detect lung pathogens in young children with cystic fibrosis","volume":"52","author":"D\u2019Sylva","year":"2017","journal-title":"Pediatric Pulmonol"},{"issue":"10","key":"10.1016\/j.chest.2020.06.044_bib10","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1164\/rccm.201501-0061OC","article-title":"PRAGMA-CF: a quantitative structural lung disease computed tomography outcome in young children with cystic fibrosis","volume":"191","author":"Rosenow","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2020.06.044_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1479972311433575","article-title":"Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis","volume":"9","author":"Sequeiros","year":"2012","journal-title":"Chron Respir Dis"},{"issue":"7","key":"10.1016\/j.chest.2020.06.044_bib12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/thoraxjnl-2012-202342","article-title":"Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age","volume":"68","author":"Byrnes","year":"2013","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.chest.2020.06.044_bib13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jcf.2015.02.007","article-title":"Treatment and demographic factors affecting time to next pulmonary exacerbation in cystic fibrosis","volume":"14","author":"VanDevanter","year":"2015","journal-title":"J\u00a0Cyst Fibros"},{"issue":"11","key":"10.1016\/j.chest.2020.06.044_bib14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/thx.2006.061366","article-title":"Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria","volume":"61","author":"Block","year":"2006","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.chest.2020.06.044_bib15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcf.2017.04.005","article-title":"Standardized Treatment of Pulmonary Exacerbations (STOP) study: observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations","volume":"16","author":"Sanders","year":"2017","journal-title":"J\u00a0Cyst Fibros"},{"issue":"1","key":"10.1016\/j.chest.2020.06.044_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1513\/AnnalsATS.201407-338OC","article-title":"Chest computed tomography predicts the frequency of pulmonary exacerbations in children with cystic fibrosis","volume":"12","author":"Sanders","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.chest.2020.06.044_bib17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/MCP.0b013e32834b8c04","article-title":"Pulmonary exacerbations in cystic fibrosis","volume":"17","author":"Stenbit","year":"2011","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"10.1016\/j.chest.2020.06.044_bib18","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1378\/chest.13-0693","article-title":"Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations","volume":"144","author":"Shoki","year":"2013","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2020.06.044_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1513\/pats.200703-044BR","article-title":"Sputum biomarkers of inflammation in cystic fibrosis lung disease","volume":"4","author":"Sagel","year":"2007","journal-title":"Proc Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.chest.2020.06.044_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088567","article-title":"Candidate markers associated with the probability of future pulmonary exacerbations in cystic fibrosis patients","volume":"9","author":"Wojewodka","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.chest.2020.06.044_bib21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jcf.2015.01.007","article-title":"Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients","volume":"14","author":"Waters","year":"2015","journal-title":"J\u00a0Cyst Fibros"},{"issue":"5","key":"10.1016\/j.chest.2020.06.044_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcf.2012.04.006","article-title":"Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis","volume":"11","author":"Asner","year":"2012","journal-title":"J\u00a0Cyst Fibros"},{"issue":"5","key":"10.1016\/j.chest.2020.06.044_bib23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jcf.2017.04.004","article-title":"Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis","volume":"16","author":"VanDevanter","year":"2017","journal-title":"J\u00a0Cyst Fibros"},{"issue":"2","key":"10.1016\/j.chest.2020.06.044_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2011.954","article-title":"Effect of bronchoalveolar lavage\u2013directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized TrialBAL\u2013directed therapy in cystic fibrosis","volume":"306","author":"Wainwright","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.chest.2020.06.044_bib25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1164\/rccm.200601-107OC","article-title":"Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage","volume":"175","author":"Jackson","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2020.06.044_bib26","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/cea.12454","article-title":"The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children: clinical tools or scientific toys?","volume":"45","author":"van Mastrigt","year":"2015","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.chest.2020.06.044_bib27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.freeradbiomed.2008.06.026","article-title":"Exhaled 8-isoprostane and prostaglandin E2 in patients with stable and unstable cystic fibrosis","volume":"45","author":"Lucidi","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.chest.2020.06.044_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152156","article-title":"Biomarkers in exhaled breath condensate are not predictive for pulmonary exacerbations in children with cystic fibrosis: results of a onyear observational study","volume":"11","author":"van Horck","year":"2016","journal-title":"PLoS One"},{"issue":"S48","key":"10.1016\/j.chest.2020.06.044_bib29","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ppul.23768","article-title":"Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers","volume":"52","author":"Giddings","year":"2017","journal-title":"Pediatr Pulmonol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220318389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220318389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:27:16Z","timestamp":1757924836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369220318389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0012369220318389"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2020.06.044","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BAL Inflammatory Markers Can Predict Pulmonary Exacerbations in Children With Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2020.06.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}